LogoLogoLogoLogoLogo
  • Portfolio
    • Active Portfolio
    • Portfolio Alumni
    • Portfolio Jobs
  • News
    • In the News
    • Portfolio News
    • Press Releases
  • About Us
    • Our Team
    • Contact Us
    • About McKesson
  • Portfolio
    • Active Portfolio
    • Portfolio Alumni
    • Portfolio Jobs
  • News
    • In the News
    • Portfolio News
    • Press Releases
  • About Us
    • Our Team
    • Contact Us
    • About McKesson

Guardant Health Raises $360 Million in Race to Create Cancer Blood Tests

Cancer Start-Up GRAIL Added One of Silicon Valley’s Best-Known Biotech VCs to Its Board

GRAIL Closes Over $900 Million Initial Investment in Series B Financing to Develop Blood Test to Detect Cancer Early

  • 1
  • 2
  • 3
  • 4
  • 5

Subscribe to McKesson Ventures

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

McKesson Ventures

We partner with companies that are driving and enabling positive change for key stakeholders on all sides of the health care economy.

Find out more about McKesson

Portfolio News

  • The Future of Care Demands a Virtual Health Ecosystem

  • Is the COVID Vaccine the Shot in the Arm We Need for Healthcare Access?

  • Andrew Dudum, Hims & Hers, on disrupting healthcare by reimagining the patient experience

  • Keeping Physicians Independent: Dr Patricia Salber Interviews Dr Farzad Mostashari

McKesson Ventures News

  • Real-World Evidence Should Be Part of Clinical Trials in Oncology
  • McKesson Ventures’ Carrie Hurwitz Williams Recognized as GCV Rising Star
  • Silicon Valley Boomer Venture Summit Announces Finalists for $10K Business Plan Competition and The Silicon Valley Innovation Competition 2019, Sponsored by AARP Innovation Labs
  • GCV Powerlist 2018: Tom Rodgers
2015 McKesson Ventures | Privacy Notice | Disclaimer
@McK_Ventures
McKesson Ventures LinkedIn